(Q43683844)

25 November 2017

Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer (English)

1 reference

25 November 2017

Hayakawa H

1

1 reference

25 November 2017

Komada Y

2

1 reference

25 November 2017

Hirayama M

3

1 reference

25 November 2017

Hori H

4

1 reference

25 November 2017

Ito M

5

1 reference

25 November 2017

Sakurai M

6

1 reference

25 November 2017

1 July 2001

1 reference

25 November 2017

Pediatric Blood Cancer

1 reference

25 November 2017

37

1 reference

25 November 2017

1

1 reference

25 November 2017

4-9

1 reference

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

25 November 2017

1 reference

Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients

21 January 2018

1 reference

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

21 January 2018

1 reference

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods

21 January 2018

1 reference

Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage

21 January 2018

1 reference

Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II. Clinical studies

21 January 2018

1 reference

Normal values for noninvasive estimation of left ventricular contractile state and afterload in children.

21 January 2018

1 reference

Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology

21 January 2018

1 reference

Early and delayed clinical cardiotoxicity of doxorubicin

21 January 2018

1 reference

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects

21 January 2018

1 reference

Alterations in left ventricular diastolic function with doxorubicin therapy

21 January 2018

1 reference

Review of tests for monitoring doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MPO.1155

1 reference

25 November 2017

1 reference